Abstract
IntroductionPirfenidone has undergone NICE approval and is recommended for patients with IPF if the FVC is 50–80% 1. We hypothesised that the NICE guidance would disadvantage a significant cohort of...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have